Calci Medica
Biotechnology, 275 Shoreline Dr, La Jolla, California, 94065, United States, 11-50 Employees
Phone Number: 85********
Who is CALCIMEDICA
CalciMedica is a privately held, clinical stage biotechnology company with a platform focused on CRAC channel drug discovery and development for the treatment of acute and severe inflamma...
Read More
-
Headquarters: 275 Shoreline Dr, La Jolla, California, 94065, United States
-
Date Founded: 2007
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
-
CEO:
Rachel Leheny
Email
Phone
Industry: Biotechnology
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from CALCIMEDICA
CalciMedica Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding CalciMedica
Answer: CalciMedica's headquarters are located at 275 Shoreline Dr, La Jolla, California, 94065, United States
Answer: CalciMedica's phone number is 85********
Answer: CalciMedica's official website is https://calcimedica.com
Answer: CalciMedica's revenue is $10 Million to $25 Million
Answer: CalciMedica's SIC: 2834
Answer: CalciMedica has 11-50 employees
Answer: CalciMedica is in Biotechnology
Answer: CalciMedica contact info: Phone number: 85******** Website: https://calcimedica.com
Answer: CalciMedica is a privately held, clinical stage biotechnology company with a platform focused on CRAC channel drug discovery and development for the treatment of acute and severe inflammatory diseases. The Company was founded in 2007 by Ken Stauderman, CalciMedicas Chief Scientific Officer, and colleagues at Torrey Pines Therapeutics in San Diego and Harvards Center for Blood Research in Cambridge, MA. Dr. Staudermans work includes the discovery of the role of STIM1, which works in concert with Orai1 in the CRAC channels targeted by CalciMedicas drugs. The Company has a portfolio of highly selective CRAC channel inhibitor drugs that it is developing to improve outcomes for patients with acute inflammatory indications. It has also assembled a portfolio of patents and patent applications covering those compounds as well as different aspects of CRAC channel biology.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month